Further, inhibiting both BCL-2 and BCR-ABL is sufficient to induce apoptosis in CML stem cells in a murine CML model and TKI-resistant BP-CML patient samples35. The gene discussed is BCL2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.